SUBSTITUTE SHEETS (RULE 26) Claims We Claim Claim 1: A process for producing Arg 34 GLP-l (9-37) peptide comprising the steps of: a) culturing a host cell comprising a nucleotide sequence encoding of Formula (II) under suitable conditions for expression, Insoluble tag Fusion tag Arg 34 GLP-l (9-37) Formula (II) wherein, insoluble tag is a nucleotide sequence of Alanine- Valine
doi: 10.1007/s10741-024-10450-6 37
This opens new innovation opportunities in high-protein, fibre-rich, micronutrient-packed formats across ready-to-eat and convenience segments
Tell your health care provider right away if you get symptoms which may include: pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools
Examining the Evidence As of April 2024, there is no established clinical evidence linking Mounjaro (tirzepatide) directly to an increased risk of blood clots or venous thromboembolism